The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) conference provides experts with an advanced understanding of the normal pediatric development and physiology of diseases of the gastrointestinal tract and liver.

The Children’s National Hospital gastroenterology team was due to present in-person at the conference but were unable to as a result of the COVID-19 pandemic. Instead they presented educational sessions virtually to gastroenterology experts across the country. The presentations spanned a variety of topics and are listed below:

• Trisomy 21: Not all duodenal abnormalities are Celiac Disease
• Celiac Kids Research Consortium (CeliacKIDS)
• Postoperative complications in pediatric IBD patients on biologic therapy undergoing intra-abdominal surgery
• 6 week infliximab trough levels as predictor of therapeutic maintenance infliximab trough levels and patient outcomes
• Inflammatory bowel disease characteristics in pediatric patients of South Asian origin in the United States
• Investigating treatment response rates in pediatric inflammatory bowel disease patients after switching biologics
• Severely elevated fecal calprotectin in a pediatric patient with persistent giardiasis
• Persistent hypoglycemia after treatment of gestational alloimmune liver disease (GALD)

The 2021 annual conference will be held on November 4-6 in Nashville, Tennessee.